Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Symptoms in Persons With Either Active or Inactive Crohn's Disease Are Agnostic to Disease Phenotype: The Magic in Imagine Study.
Bernstein CN, Nugent Z, Panaccione R, Marshall DA, Kaplan GG, Dieleman LA, Vanner S, Graff LA, Otley A, Jones J, Buresi M, Murthy S, Borgaonkar M, Bressler B, Bitton A, Croitoru K, Sidani S, Fernandes A, Moayyedi P. Bernstein CN, et al. Among authors: buresi m. J Clin Gastroenterol. 2025 Jan 22. doi: 10.1097/MCG.0000000000002137. Online ahead of print. J Clin Gastroenterol. 2025. PMID: 39853241
Crohn's Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study.
Bernstein CN, Panaccione R, Nugent Z, Marshall DA, Kaplan GG, Vanner S, Dieleman LA, Graff LA, Otley A, Jones J, Buresi M, Murthy S, Borgaonkar M, Bressler B, Bitton A, Croitoru K, Sidani S, Fernandes A, Moayyedi P. Bernstein CN, et al. Among authors: buresi m. Inflamm Bowel Dis. 2025 Jan 6;31(1):113-122. doi: 10.1093/ibd/izae055. Inflamm Bowel Dis. 2025. PMID: 38537257 Free PMC article.
Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease.
Kotze PG, Ma C, Almutairdi A, Al-Darmaki A, Devlin SM, Kaplan GG, Seow CH, Novak KL, Lu C, Ferraz JGP, Stewart MJ, Buresi M, Jijon H, Mathivanan M, Heatherington J, Martin ML, Panaccione R. Kotze PG, et al. Among authors: buresi m. Aliment Pharmacol Ther. 2018 Sep;48(6):626-637. doi: 10.1111/apt.14919. Epub 2018 Jul 31. Aliment Pharmacol Ther. 2018. PMID: 30063077
Esophageal motility in systemic sclerosis before and after autologous hematopoietic cell transplantation.
Woo MMK, Levin D, Li DY, David J, Buresi M, Gupta M, Nasser Y, Andrews CN, Durand C, Osman MS, Jamani K, Weatherald J, Johannson KA, Howlett JG, Hemmati I, Kim H, Curley M, Storek J. Woo MMK, et al. Among authors: buresi m. Clin Rheumatol. 2023 Dec;42(12):3267-3274. doi: 10.1007/s10067-023-06766-7. Epub 2023 Sep 13. Clin Rheumatol. 2023. PMID: 37702810
Response to Paterson et al.
Rezaie A, Buresi M, Rao S. Rezaie A, et al. Among authors: buresi m. Am J Gastroenterol. 2017 Dec;112(12):1889-1892. doi: 10.1038/ajg.2017.373. Am J Gastroenterol. 2017. PMID: 29215623 No abstract available.
22 results